Afuresertib (GSK-2110183)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 16:12, 25 May 2015 by Jwarner (talk | contribs) (Jwarner moved page Afuresertib to Afuresertib (GSK2110183))
Jump to navigation Jump to search

Mechanism of action

Oral AKT1 inhibitor

Preliminary results

Multiple myeloma

  1. Spencer A, Yoon SS, Harrison SJ, Morris SR, Smith DA, Brigandi RA, Gauvin J, Kumar R, Opalinska JB, Chen C. The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma. Blood. 2014 Oct 2;124(14):2190-5. Epub 2014 Jul 29. link to original article PubMed
Retrieved from "https://hemonc.org/w/index.php?title=Afuresertib_(GSK-2110183)&oldid=7999"